Seres Therapeutics Inc. (MCRB) has announced that its shareholders have approved the proposed sale of the company's VOWST business to Société des Produits Nestlé S.A.
The transaction is anticipated to be finalized on September 30, 2024, pending the fulfillment of customary closing conditions.
In June 2024, Seres Therapeutics disclosed that it had entered into a non-binding memorandum of understanding (MoU) with Nestlé Health Science concerning the sale of its VOWST assets.
